This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Vaginal Inflammation or Vaginal Infections
and you are
between 21 and 45
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This study investigates the response of vaginal and cervical tissue after exposure to three vaginal products: hydroxyethyl cellulose (HEC) placebo, nonoxynol-9 (N9) and imiquimod (IMQ) cream.

Provided treatments

  • Drug: Imiquimod
  • Other: Placebo
  • Drug: Nonoxynol-9

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01593124. The sponsor of the trial is CONRAD and it is looking for 20 volunteers for the current phase.
Official trial title:
Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation